A phase II study of leucovorin (LV)-modulated continuous infusion (CI) fluorouracil (DU) + CPT-11 alternating with LV-modulated CI FU + Oxaliplatin (L-OHP) in advanced colorectal cancer (CCR): high activity and low toxicity

✍ Scribed by Aschele, A.; Lonardi, S.; Sartor, L.; Perin, A.; Koussis, B.; Nicoletto, O.; Monfardini, S.

• Book ID: 121954998
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 194 KB
• Volume: 37
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(01)81633-6